Asbestos is an established cause of ovarian cancer, placed in the same evidence category by the World Health Organization's cancer agency as asbestos lung cancer and mesothelioma. For many women, the exposure wasn't a jobsite at all but the bathroom shelf: talcum powder that may have been contaminated with asbestos. If you've been diagnosed with ovarian cancer and used talcum powder regularly, or were exposed to asbestos another way, you may have a claim. Unlike most asbestos cancers, ovarian cancer isn't paid by any asbestos trust that's currently open, but two real paths remain: lawsuits against the companies that made the products, and disability benefits. Call us at 833-4-ASBESTOS for a free, confidential case review.
You don't need the product names or old records. No fee unless we recover compensation for your family.
Quick answers
| Can asbestos cause ovarian cancer? | Yes. The world's cancer authorities recognize asbestos as an established cause of ovarian cancer. |
|---|---|
| How would I have been exposed? | Often through talcum powder that may have been contaminated with asbestos, used over many years, or by living with an asbestos worker, or through a job. |
| Do the asbestos trusts pay ovarian cancer claims? | Not today. No currently open trust pays them, though some trusts that haven't opened yet, including the Imerys talc trust, may pay them in the future. For now, ovarian cancer is pursued through lawsuits against talc and asbestos manufacturers, and through disability benefits. |
| Do I need to prove asbestos was the only cause? | No. In most states asbestos only has to have been a substantial contributing cause, not the only one, though the exact standard and the proof required vary by state. |
| How long after exposure does it appear? | Usually decades. Asbestos-related cancers have long latency. |
| What does it cost to talk to you? | Nothing. Call 833-4-ASBESTOS for a free, no-obligation review. |
Why this one is personal for us
When my mom was diagnosed with ovarian cancer in the 1990s, we thought it was just one of those tragic things that happen. Years later, we began learning the truth, that the bath powder she used every day may have been contaminated with asbestos. I can still picture the fine white dust clinging to the blue throw rug in our bathroom. Thankfully she recovered after surgery, but I can't help but wonder: did that baby powder play a role in her cancer?
— Justinian C. Lane, Founding Partner
That question, the one so many families are left asking, is why this page exists and why we do this work.
How asbestos causes ovarian cancer
Asbestos is a Group 1 human carcinogen, the highest classification there is, and its link to ovarian cancer is recognized as causal. After weighing the evidence in 2009, the World Health Organization's IARC concluded there was sufficient evidence that asbestos causes ovarian cancer, placing it in the same established-causation category as lung cancer, laryngeal cancer, and mesothelioma, though the ovarian evidence rests on fewer cases and a more modest excess risk.1 The Helsinki expert group added ovarian cancer to its list of asbestos-related diseases in 2014.2
The numbers back it up. A 2011 meta-analysis of women with heavy occupational asbestos exposure, in industries like asbestos cement, textiles, and mining, found their ovarian cancer death rate ran about 77% higher than expected (a standardized mortality ratio of 1.77),3 and the individual studies IARC reviewed ranged from modestly to several times elevated.1 A more recent meta-analysis reached the same place, with a combined figure of about 1.72; the newest studies' estimate was higher (about 2.04) but imprecise.4 One caveat runs through this research: in older studies based on death certificates, some cancers recorded as ovarian may actually have been peritoneal mesothelioma. Both meta-analyses took that into account and still found an excess, but it remains an acknowledged limitation. These are relative figures from industrial workers, not measurements of risk for talc users. Ovarian cancer is uncommon, with a lifetime risk of roughly 1 in 90 for women in general, so even a relative increase of this size is a modest absolute one.
How asbestos is thought to reach the ovaries
Exactly how asbestos fibers travel to the ovaries is still being studied, but two main routes are proposed. The first is inhalation followed by migration: fibers breathed in can move through the lymphatic and circulatory systems into the abdominal cavity, where they can reach the ovaries.
The second, specific to powder used in the genital area, is upward migration through the reproductive tract, from the perineum through the uterus and fallopian tubes to the ovaries. Once fibers lodge in ovarian tissue, they may set off the chronic inflammation, oxidative stress, and DNA damage that can drive cancer. Researchers have reported finding asbestos fibers and talc particles in the ovarian and pelvic tissue of exposed women in a small case series,5 though the transport mechanism itself remains an active area of study.
How Asbestos Contaminates Talcum Powder
For many women, asbestos and ovarian cancer come together through one everyday product: talcum powder.
Talc and asbestos are geological neighbors. They form under the same conditions, in the same magnesium-rich rock, which means asbestos veins often run right through talc deposits. Some cosmetic talc was historically mined in places, like parts of northern Italy, where tremolite and anthophyllite asbestos sit alongside the talc, and Vermont, where tremolite has been reported. When the rock is mined and milled into powder, asbestos fibers can come with it, invisible to the eye but present in the finished product. And once talc and asbestos are ground together that finely, separating them again is nearly impossible. Picture emptying a salt shaker into a bowl of sugar, stirring it through, and then trying to pick out every last grain of salt; at the scale of milled mineral particles, asbestos and talc are just as mixed and just as hard to pull cleanly apart. That's part of why talc marketed as "asbestos-free" has repeatedly tested positive for asbestos.
This isn't a fringe claim, either. In 2019, the FDA confirmed asbestos in a sample of Johnson & Johnson Baby Powder from one production lot (J&J disputed the result and recalled the lot),6 and testing has found it in talc products sold for decades, including after companies said they had switched to "clean" sources of talc. The FDA's more recent sampling of talc cosmetics has found no asbestos in the products tested,7 which shows how much results depend on which products and lots get tested, and how. And in a case series of 10 women with serous ovarian cancer who were long-term talc users, researchers reported finding talc in all 10 and asbestos fibers of the specific types (tremolite, anthophyllite) characteristic of contaminated cosmetic talc in 8, in their ovarian and pelvic tissue.5
Asbestos is an established cause of ovarian cancer, and talc contaminated with asbestos exposes whoever uses it, often daily, for years. So in any one woman's case, the question isn't whether asbestos can cause ovarian cancer. The questions are whether the powder she used was contaminated, how much she was exposed to, and whether that exposure contributed to her cancer, and that's what we investigate: the specific products, where their talc was mined, and the testing done on those product lines.
There's also a separate, less settled question: whether talc itself, without asbestos, raises ovarian cancer risk. In 2024, IARC classified talc as "probably carcinogenic to humans" (Group 2A), based on sufficient evidence in laboratory animals and strong mechanistic evidence, while the human evidence for ovarian cancer was judged limited, because in most of the studies asbestos contamination and reporting bias couldn't be ruled out.8 Studies that asked women with and without ovarian cancer about past powder use have generally found modest increases in risk, while the largest pooled analysis of women followed forward over time found no statistically significant association.9 Asbestos remains the established cause; for talc alone, the evidence is still debated.
What the testing has found
The brands of talcum powder with asbestos contamination are major brands. Dr. William Longo of Materials Analytical Services has analyzed hundreds of containers of cosmetic talc, gathered from people who used them, collectors, store shelves, and the companies' own archives, and his results have been summarized in expert reports filed in talc litigation. Asbestos turned up in 79 of 91 containers of Colgate-Palmolive's Cashmere Bouquet, with vintages from 1910 to the early 1990s, and in 78 of about 118 containers of Johnson's Baby Powder and Shower to Shower made from the 1940s through the 2000s; according to the report, 72 of those 118 containers were obtained directly from Johnson & Johnson. Every container of Chanel No. 5 bath powder (24, made from the late 1930s through the 2000s) and Jean Naté powder (15) that was tested contained asbestos.10
248 containers tested by Materials Analytical Services (Dr. William Longo), as summarized in expert reports filed in talc litigation; bar length shows how many containers were tested
Source: Materials Analytical Services (Dr. William Longo) testing of cosmetic talc, as summarized in expert reports filed in [talc litigation](/library/lexicon/talc-litigation). “Below detectable limit” means no asbestos was found at the method’s sensitivity, not that the product was asbestos-free.
These were containers gathered where they could be found, from sellers, collectors, and resale sites, and in many cases pulled directly from the companies' own archives, so the figures describe the products tested, not every can ever sold. What they show is that contamination didn't sit with one company or one bad decade. It appeared in products from multiple manufacturers, across most of the twentieth century, including in samples whose paper trail led straight back to the makers.
This was on the federal government's radar early. In 1968, scientists with the U.S. Public Health Service tested 22 cosmetic talcum powders bought straight off retail shelves and found respirable fibers in every one of them. Most of that was fibrous talc, but the authors flagged the probable presence of tremolite, anthophyllite, and chrysotile, the asbestos minerals that occur in talc deposits, and concluded that cosmetic talc should be treated as a real source of the asbestos-type fibers then being found in human lungs.11
The contamination traces back to specific places in the ground. In a 2014 study, three independent laboratories examined one historic talc powder in depth and followed its raw material to the three mines that supplied it: Willow Creek in southwest Montana, the Regal mine near Murphy, North Carolina, and the Val Chisone valley of the Italian Piedmont. All three sit in geology where asbestos runs alongside the talc (anthophyllite and tremolite in all three, with chrysotile reported in the Italian ore), and all three laboratories confirmed those same fibers in the finished powder.12 In other words, the risk of contamination comes from the mines, not the brands. Talc drawn from an asbestos-bearing deposit can carry the fibers into any product made from it, under any brand name. A company can change the wording on a bottle without changing what came out of the ground.
The researchers didn't stop at testing the contents of the can, either. They built a chamber to the dimensions of one user's bathroom, applied the powder the ordinary way (shaken from a container, dusted from a puff), and measured the air she would have breathed. Normal use lofted inhalable asbestos into the breathing zone. And in the lung and lymph-node tissue of a woman who had used that powder and died of mesothelioma, they found asbestos fibers. The contamination could be followed the whole way: out of the mine, into the milled product, into the air during use, and into the body.
One more finding explains why "asbestos-free" labels can be misleading. A fourth laboratory had reported no asbestos in twenty of these products. It used the same kind of electron microscope, but examined only 10 to 25 small fields of each sample, where the study laboratories examined several hundred. Of those same twenty products, one study laboratory found asbestos in all twenty and another in sixteen. When the authors re-examined the fourth lab's own preparations, they found asbestos fibers its analysis hadn't recorded: anthophyllite in eight, tremolite in six, and chrysotile in two. How often asbestos is "found" depends heavily on how hard, and how carefully, someone looks. It's the same reason a powder can be sold as asbestos-free and still expose the person using it.
Why one method finds asbestos and another doesn't
Two kinds of microscope get used to look for asbestos, and they don't see the same thing. Polarized light microscopy (PLM), a light microscope, is the quick, standard way to screen a bulk sample, and it can identify asbestos by the way the fibers bend light. But it has low sensitivity. It can't resolve fibers much thinner than a few tenths of a micron, and many asbestos fibers, especially the thin amphiboles and chrysotile fibrils that turn up in contaminated talc, are finer than that, so they never register. And it only reliably catches asbestos when there's a fair amount of it; trace contamination can sit below that level and read as "none found."
Transmission electron microscopy (TEM) uses a beam of electrons instead of light, so it resolves fibers more than ten times thinner, down to single fibrils, and at far lower concentrations, and paired with a chemical-fingerprint and crystal-structure analysis it confirms whether a fiber is asbestos and which type. So when one lab reports "none detected" and another finds asbestos in the same product, it often isn't a contradiction: the fibers may have been too thin or too sparse for the less sensitive method, or for a less thorough search, to catch. Differences in sampling, preparation, and how analysts classify a fiber matter too, so each disagreement has to be read in light of the methods used. But a clean result from a method that can't see the smallest fibers isn't the same as a clean product.
What kinds of products are made with talc
Talc is one of the most widely used minerals there is, valued because it's soft, absorbs moisture and oil, and holds up to heat. That softness puts it in two very different worlds: the powders and cosmetics people put on their bodies, and the industrial materials built into homes, cars, and everyday goods.
On the cosmetic side, talc is the classic base for body powder and baby powder, but it reaches well beyond the bottle on the nursery shelf. It turns up in face powders, pressed powders, blush, eyeshadow, and foundation, in foot powders and dry shampoos, and in some deodorants and antiperspirants, anywhere a product needs to feel smooth, stay dry, or resist caking. For ovarian cancer specifically, the use that matters most is the everyday application of body and dusting powders to the genital and perineal area, often daily and over many years. That is the exposure route at the center of most talc-related ovarian cancer claims.
Industrial talc is the same mineral put to harder use, and it's far more common than most people realize. It works as a filler and functional ingredient in ceramics and tile, paint, plastics (including molded automotive parts), paper, rubber, roofing shingles, joint compound, caulk, and even crayons, among many others. Industrial grades were historically held to looser purity standards than cosmetic talc, and some industrial sources, like the tremolite- and anthophyllite-bearing talc mined in upstate New York, were known to carry asbestos.
For the people who mined, milled, and worked with that material, it was occupational exposure, and the dust sometimes followed them home as take-home asbestos exposure for their families. As with cosmetic powder, whether any given talc carried asbestos came down to where it was mined, not every product and not every brand, but enough of them, from enough sources, that the question is always worth asking.
Symptoms of ovarian cancer and why it's caught late
Ovarian cancer is often called a silent disease, not because it causes no symptoms, but because the ones it causes are easy to mistake for ordinary digestive or hormonal trouble. The difference is persistence: with ovarian cancer the symptoms tend to be frequent and ongoing rather than occasional. As a rule of thumb, signs that occur more than a dozen times a month and continue for several weeks deserve a doctor's attention.
Watch for ongoing bloating or abdominal swelling, pelvic or abdominal pain, feeling full quickly or trouble eating, changes in bowel habits, frequent or urgent urination, and unexplained fatigue. There's no routine screening test for ovarian cancer that reliably catches it early, which makes symptom awareness, and your exposure history, all the more important. If you used talcum powder for years or were exposed to asbestos, tell your doctor; it belongs in your medical record and matters to any claim. It isn't a reason for routine screening, which expert bodies recommend against for women without symptoms because it hasn't been shown to save lives. What does matter is getting new, frequent, persistent symptoms checked promptly.
One possibility is worth raising directly, because it can change everything that follows. In women, peritoneal mesothelioma (a cancer of the lining of the abdomen) can be mistaken for ovarian or primary peritoneal cancer. The two look alike on imaging and even on the cytology of abdominal fluid, and a general pathologist who rarely sees mesothelioma can read it as the more familiar ovarian cancer.
What usually separates them is immunohistochemistry, a panel of antibody stains on the tumor tissue, read together with the tumor's appearance by a pathologist experienced in peritoneal disease, sometimes with additional molecular tests when the stains aren't clear-cut. The distinction matters twice: peritoneal mesothelioma is treated differently, often with surgery and heated chemotherapy at specialized centers, and because it's one of the cancers most strongly tied to asbestos, recognizing it can open compensation routes, including the asbestos trusts, that ovarian cancer claims can't reach. If your diagnosis rested on imaging or fluid alone, it's worth asking whether the tissue was reviewed by a mesothelioma-experienced pathologist. Our page on talc and peritoneal cancer in women covers how that diagnosis is confirmed and what it means for a claim.
How ovarian cancer is diagnosed and treated
Diagnosis usually begins with a pelvic exam and a transvaginal ultrasound, often alongside a CA-125 blood test, with CT or MRI to assess spread. A definitive diagnosis comes from tissue, taken by biopsy or removed during surgery, examined by a pathologist. Treatment centers on surgery to remove as much tumor as possible (debulking), almost always paired with platinum-based chemotherapy such as carboplatin and paclitaxel. For women with BRCA mutations or related features, targeted drugs called PARP inhibitors have become an important maintenance therapy. Caught early, ovarian cancer is far more treatable, which is the whole reason exposure history and prompt evaluation matter. This is an orientation, not medical advice; your own care team will tailor a plan to your diagnosis.
Compensation, and how it helps pay for treatment
An ovarian cancer diagnosis is expensive and exhausting, and compensation exists to take that weight off you and your family. This is where ovarian cancer differs from most asbestos cancers, so it's worth being clear about how it works.
No currently open asbestos trust pays ovarian cancer claims. Some trusts that haven't opened yet, including the Imerys talc trust, may pay them in the future, but for now that's an honest limitation, and it's why the compensation path here runs through two other routes instead.
Lawsuits against talc and asbestos manufacturers. This is the main avenue. Thousands of women have brought claims against the makers of talc products found to contain asbestos, including Johnson & Johnson, and this litigation has produced significant settlements and jury verdicts. Johnson & Johnson tried three times to use a special bankruptcy maneuver (the "Texas two-step") to move these claims out of the courts; the last attempt was rejected in 2025, and the cases are back in the court system. In July 2026 J&J proposed a settlement of existing ovarian cancer claims that depends on nearly all claimants agreeing to it, so it isn't final. We'll update this page as that develops. It doesn't change the first step for you, which is finding out what you used and whether you may have a claim. Claims can be brought for the harm itself, for wrongful death by a surviving family, and in some cases for the companies' concealment of what they knew. These cases turn on showing which products you used and for how long, which is why your history matters more than anything.
Every state sets its own deadline for filing, and some are short, so the most important step is to call promptly after diagnosis, before that window closes. Find your state's asbestos filing deadlines.
Social Security Disability. If ovarian cancer keeps you from working, you may qualify for disability benefits: disability insurance (SSDI) requires enough work credits, while Supplemental Security Income (SSI) can be available without them for people with limited income and resources, and either way the illness must be expected to last at least a year or be terminal. Ovarian cancer that has spread to distant sites, or that can't be removed surgically, is on Social Security's Compassionate Allowances list, which speeds up review, though the decision itself still follows the usual rules. See if you're eligible for a Social Security disability claim.
You don't have to face this alone
You focus on your health. We'll take care of the rest.
If you've been diagnosed with ovarian cancer and used talcum powder regularly, or were exposed to asbestos another way, you may have legal options, even if your doctor never mentioned asbestos, even if it's been decades, even if your loved one has already passed. Call 833-4-ASBESTOS or contact us here for a free, confidential review. There's no fee unless we win.
References
- International Agency for Research on Cancer. Asbestos (chrysotile, amosite, crocidolite, tremolite, actinolite, and anthophyllite). In: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Vol 100C. Lyon, France: IARC; 2012:219-309.
- Wolff H, Vehmas T, Oksa P, Rantanen J, Vainio H. Asbestos, asbestosis, and cancer, the Helsinki criteria for diagnosis and attribution 2014: recommendations. Scand J Work Environ Health. 2015;41(1):5-15.
- Camargo MC, Stayner LT, Straif K, et al. Occupational exposure to asbestos and ovarian cancer: a meta-analysis. Environ Health Perspect. 2011;119(9):1211-1217. doi:10.1289/ehp.1003283
- Kim SY, Chang HK, Kwon O, Park J, Myong JP. Asbestos exposure and ovarian cancer: a meta-analysis. Saf Health Work. 2024;15(1):1-8. doi:10.1016/j.shaw.2023.11.002
- Steffen JE, Tran T, Yimam M, et al. Serous ovarian cancer caused by exposure to asbestos and fibrous talc in cosmetic talc powders: a case series. J Occup Environ Med. 2020;62(2):e65-e77. doi:10.1097/JOM.0000000000001800
- US Food and Drug Administration. FDA advises consumers to stop using certain cosmetic products. 2019. (Asbestos confirmed in a sample of Johnson & Johnson Baby Powder.)
- US Food and Drug Administration. Talc (including results of FDA testing of talc-containing cosmetic products for asbestos). Silver Spring, MD: FDA. Accessed October 27, 2026. https://www.fda.gov/cosmetics/cosmetic-ingredients/talc
- Stayner LT, Carreón-Valencia T, Demers PA, et al. Carcinogenicity of talc and acrylonitrile. Lancet Oncol. 2024;25(8):962-963. doi:10.1016/S1470-2045(24)00384-X
- O'Brien KM, Tworoger SS, Harris HR, et al. Association of powder use in the genital area with risk of ovarian cancer. JAMA. 2020;323(1):49-59. doi:10.1001/jama.2019.20079
- Moline JM. Expert report (June 23, 2021) and declaration (August 24, 2023), Cardillo talc litigation (defendant American International Industries), summarizing Materials Analytical Services (Longo WE) analyses of cosmetic talc products.
- Cralley LJ, Key MM, Groth DH, Lainhart WS, Ligo RM. Fibrous and mineral content of cosmetic talcum products. Am Ind Hyg Assoc J. 1968;29(4):350-354. doi:10.1080/00028896809343015
- Gordon RE, Fitzgerald S, Millette J. Asbestos in commercial cosmetic talcum powder as a cause of mesothelioma in women. Int J Occup Environ Health. 2014;20(4):318-332. doi:10.1179/2049396714Y.0000000081
In our case-law library
5 court decisions in our case-law library involve ovarian cancer. Among them:
- Johnson & Johnson v. ShiverGeorgia Court of Appeals, 2021 · The Georgia Court of Appeals reversed the four trial courts' denials of Johnson & Johnson's motions to dismiss, ruling for J&J and requiring dismissal of the estates' complaints without prejudice.
- Ingham v. Johnson & JohnsonMissouri Court of Appeals, 2020 · The court reversed the judgment against Johnson & Johnson Consumer Companies on two out-of-state plaintiffs' claims and against Johnson & Johnson on all seventeen out-of-state plaintiffs' claims for lack of personal jurisdiction, rejected the defendants' other challenges, and entered a reduced judgment of $500 million compensatory and $900 million punitive against JJCI and $125 million compensatory and $715,909,091 punitive against J&J.
- Hanson v. Colgate-Palmolive CompanyU.S. District Court, Southern District of Georgia, 2018 · The district court granted Colgate-Palmolive's motions for summary judgment and partial summary judgment on punitive damages, entering judgment against Douglas Hanson on all claims because he had no evidence that his late wife was exposed to asbestos in Cashmere Bouquet talc, or at what level.
- Hanson v. Colgate-Palmolive Co.U.S. District Court, Southern District of Georgia, 2018 · The federal district court excluded the causation and contamination opinions of plaintiff Hanson's experts Gordon, Kradin and Moline and most of Webber's, and allowed the defense experts Sanchez, Mossman and Moolgavkar to testify, a ruling favoring Colgate-Palmolive.
- Bernard v. Brookfield Prop. Corp.New York Supreme Court, 2010 · The court granted defendant Ruderman's motion to dismiss the complaint and cross claims against it, without prejudice to recommencement, denied its premature summary judgment request, and denied Colgate's cross motion to treat its late notice of claim as timely served.
Talk with an asbestos lawyer
Start with what you remember, and we'll take it from there.
This page is provided for general informational purposes and does not constitute legal advice. Every asbestos case turns on its own facts, exposure history, diagnosis, deadlines, available evidence, and applicable law. Reviewing this page does not create an attorney-client relationship. For advice about your specific situation, call 833-4-ASBESTOS for a free case review.